Patrick J McEnany Net Worth & Insider Trades
Patrick J McEnany - President and CEO, Catalyst Pharmaceuticals, Inc
What is Patrick J McEnany's Net Worth?
The current estimated net worth of Catalyst Pharmaceuticals, Inc's President and CEO, Patrick J McEnany, is estimated to be about $100.98M . Patrick J McEnany owns about 4,119,285 units of Catalyst Pharmaceuticals, Inc common stock. In the last 15 years at Catalyst Pharmaceuticals, Inc, Patrick J McEnany has sold an estimated value of $29.3M worth.
What is Patrick J McEnany's Past Insider Trading?
Patrick J McEnany's largest purchase order was 500,000 units , worth over $1.12M on November 22, 2022. Patrick J McEnany's largest sale order was 1,027,611 units , worth over $15.83M on September 15, 2022. In total, Patrick J McEnany has made about 73 transactions over 15 years of their time at Catalyst Pharmaceuticals, Inc. Patrick J McEnany usually trades in December, with the busiest year in 2008. The most recent transaction was a sale order of 26,151 units , worth over $345.98K on May 17, 2023.
Patrick J McEnany
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
What was Patrick J McEnany's Salary in 2018?
As President and CEO of Catalyst Pharmaceuticals, Inc, Patrick J McEnany has a total base salary of $524,236 . The vast majority of their compensation came in the form of a bonus of $332,063 , stock awards of $ , other earnings, plans or compensations of $3,461,504 , other earnings, plans or compensations of $3,461,504 , and other compensation of $ .
What is Patrick J McEnany's' Mailing Address?
- Mailing address is C/o Thermogenesis Corp 2711 Citrus Road Rancho Cordova CA 95742 CA
Catalyst Pharmaceuticals, Inc Executive Compensation
Name |
Year
|
Salary
|
Bonus
|
Stock Awards
|
Other Earnings Plans or Compensations
|
Other Earnings Plans or Compensations
|
Other Compensation
|
Other Earnings Plans or Compensations
|
|---|---|---|---|---|---|---|---|---|
| Patrick J. McEnany | 2018 | $524,236 | $332,063 | $ | $3,461,504 | $3,461,504 | $ | $3,461,504 |
| Steven R. Miller, COO and CSO | 2018 | $427,441409,325 | $188,600 | $ | $1,655,195 | $1,655,195 | $11,000 | $1,655,195 |
| Gary Ingenito, CM&RO | 2018 | $399,373 | $194,810 | $ | $1,666,645 | $1,666,645 | $26,192 | $1,666,645 |
| No matching records found | ||||||||
Source: https://www.sec.gov/Archives/edgar/data/1369568/000119312520188818/d932120ddef14a.htm
What are Catalyst Pharmaceuticals, Inc's Past Insider Trades?
Catalyst Pharmaceuticals, Inc's most recent insider trade came on May 17, 2023 by Patrick J McEnany who sold 26,151 units worth $345.98K . In the last 16 years, insiders at Catalyst Pharmaceuticals, Inc have sold an estimated value of $61.74M and bought an estimated value of $19.81M worth of shares. Insider trading is most common in December, with the busiest year in 2022. The most active traders at the company are Patrick J McEnany, President and CEO, Charles B. O'Keeffe, Director, and Philip H Coelho, Director .
CATALYST PHARMACEUTICALS, INC. Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||